ANASSA announces that a second state-of-the-art molecular analysis machine for the novel coronavirus SARS-COV-2. The acquisition of the second analyst also upgrades ANASSA in the context of dealing with the Covid-19 pandemic for early molecular detection and laboratory confirmation of suspected cases, through the method REAL TIME – PCR.
Σας βοήθησε αυτό το άρθρο;
ΝαιΌχι